1095559-57-1Relevant articles and documents
SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1
-
Paragraph 00787, (2014/07/08)
Provided herein are small molecule neurotensin receptor agonists, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.
Synthesis, resolution, and application of cyclobutyl- and adamantyl-quinazolinap ligands
Fekner, Tomasz,Mueller-Bunz, Helge,Guiry, Patrick J.
experimental part, p. 5055 - 5066 (2009/05/26)
An expedient, seven-step synthesis of two new members of the Quinazolinap ligand family, 2-cyclobutyl- and 2-(1-adamantyl)-Quinazolinaps, has been developed. The racemic ligands have been efficiently resolved by fractional crystallization of their diastereomeric palladacycle complexes. The enantioenriched ligands provide good levels of enantioselection (ee's up to 89%) in a prototypical PdII-catalyzed allylic alkylation reaction. 2-Cyclobutyl-Quinazolinap has been further functionalized at the 2-position via metalation with a superbase followed by reaction with a range of electrophiles. Wiley-VCH Verlag GmbH & Co. KGaA, 2008.